WALD:NSD-Waldencast Acquisition Corp (USD)

COMMON STOCK | Household & Personal Products |

Last Closing

USD 3.27

Change

0.00 (0.00)%

Market Cap

USD 0.42B

Volume

0.05M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Waldencast plc operates in the beauty and wellness industry. It engages in developing, acquiring, accelerating, and scaling various brands. The company provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians. It also offers clean makeup products under the Milk Makeup brand. The company sells its products to dermatologists, plastic surgeons, and other physicians who focuses on aesthetic and therapeutic skincare, including physicians on site at medical spas, through its direct sales force, as well as through distribution partners. Waldencast plc was incorporated in 2020 and is headquartered in White Plains, New York.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-03 )

Largest Industry Peers for Household & Personal Products

Symbol Name Price(Change) Market Cap
IPAR Inter Parfums Inc

N/A

USD 3.90B
NWL Newell Brands Inc

N/A

USD 3.73B
HELE Helen of Troy Ltd

N/A

USD 1.47B
EWCZ European Wax Center Inc

N/A

USD 0.43B
HNST Honest Company Inc

N/A

USD 0.38B
WALDW Waldencast Acquisition Corp

N/A

USD 0.37B
DSY Big Tree Cloud Holdings Limite..

N/A

USD 0.24B
SKIN Beauty Health Co

N/A

USD 0.21B
UG United-Guardian Inc

N/A

USD 0.06B
RAY Raytech Holding Limited Ordina..

N/A

USD 0.03B

ETFs Containing WALD

N/A

Market Performance

  Market Performance vs. Industry/Classification (Household & Personal Products) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -70.11% 36% F 8% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return -70.11% 36% F 8% B-
Trailing 12 Months  
Capital Gain -63.46% 36% F 9% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return -63.46% 36% F 9% A-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -12.98% 45% F 19% F
Dividend Return -12.98% 45% F 19% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 19.88% 100% F 78% C+
Risk Adjusted Return -65.26% 27% F 11% F
Market Capitalization 0.42B 71% C- 59% D-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector